Lebanon’s pharmaceutical overall market size is considered to be small by regional – as well as global – standards, with a population of around 6M. Lebanon’s pharmaceutical market is calculated to have been worth LBP 2.91trn (USD1.93B) in 2018, accounting for 3.3% of the country’s GDP and 44% of total healthcare expenditure. This translates into per capita spending of USD281 – substantially higher than regional spending for Arab Gulf Levant countries. Most of the market is accounted for by prescription medicines, which represents 83% of the total value.
For the full report, kindly follow the link:
Lebanon Pharmaceutical and Healthcare Sector